Cri-du-chat and SOTOS Probe Combination
Cri-du-chat syndrome consists of multiple congenital anomalies, mental retardation, microcephaly, abnormal face and a mewing cry in infants. Cri-du-chat Syndrome is associated with deletions, which vary in size, of part of the short arm of chromosome 51.
The estimated prevalence varies between 1 in 20,000 to 1 in 50,000 births2, making it one of the more common deletion syndromes. A critical chromosomal region involved in the high-pitched cry has been mapped to the proximal part of chromosome band 5p15.33. The region involved in the remaining features of the syndrome has been mapped to 5p15.23,4,5.
SOTOS syndrome is a neurological disorder characterised by a distinctive facial appearance, overgrowth in childhood and developmental delay6. Malignant tumour formation has also been reportedly associated with SOTOS syndrome7.
NSD1, a gene encoding a histone methyltransferase, and implicated in chromatin regulation8, was identified as the gene disrupted by the 5q35 breakpoint in a patient carrying a chromosomal translocation9. Haploinsufficiency of the NSD1 gene appears to be the major cause of SOTOS syndrome.
The quality of the products we have received from Cytocell have been excellent. The FISH probes they provide to us give intense, strong signals and are a pleasure to count. What has really stood out however has been the level of support and assistance provided by Cytocell’s application specialists. The team worked very closely alongside our own during the adoption of this product and spent many hours with us perfecting the technique, going above and beyond what I would expect during the transition period. Source BioScience absolutely demand high quality products and service to be able to deliver our results with confidence, and that is what we have received from Cytocell. Neil Ryan, Laboratory Operations Manager at Source BioScience
1. Lejeune J et al., C R Hebd Seances Acad Sci 1963;257:3098-102
2. Niebuhr E et al., Hum Genet 1978;44:227-75
3. Mainardi PC et al., J Med Genet 2001;38:151-8
4. Overhauser J et al., Hum Mol Genet 1994;3:247-52
5. Wu Q et al., Eur J Hum Genet 2005;13:475-85
6. Cole TR and Hughes HE, J Med Genet 1994;31(1):20-32
7. Maldonado V et al., Am J Dis Child 1984;138:486-8
8. Tatton-Brown K and Rahman N, Eur J Hum Genet 2007;15:264-71
9. Kurotaki N et al., Nat Genet 2002;30:365-6
This product is intended to be used on Carnoy’s solution (3:1 methanol/acetic acid) fixed peripheral blood samples.